{"id":495,"date":"2014-11-11T12:29:47","date_gmt":"2014-11-11T11:29:47","guid":{"rendered":"http:\/\/www.futur.glycogenoses.org\/?p=495"},"modified":"2016-01-21T17:52:18","modified_gmt":"2016-01-21T16:52:18","slug":"une-enquete-longitudinale-sur-10-ans","status":"publish","type":"post","link":"https:\/\/www.glycogenoses.org\/st_qlfctn\/une-enquete-longitudinale-sur-10-ans\/","title":{"rendered":"Une enqu\u00eate longitudinale sur 10 ans"},"content":{"rendered":"<p class=\"spip\"><b class=\"spip\">Une \u00e9quipe a r\u00e9alis\u00e9 une enqu\u00eate longitudinale aupr\u00e8s de patients pour \u00e9valuer l&rsquo;impact de la maladie sur leur vie quotidienne.<\/b><\/p>\n<p class=\"spip\">Une \u00e9tude anglo-n\u00e9erlandaise rapporte les r\u00e9sultats d&rsquo;une enqu\u00eate longitudinale r\u00e9alis\u00e9e sur 10 ans (de 2002 \u00e0 2013) aupr\u00e8s de 408 enfants et adultes atteints de maladie de Pompe dans le monde. L&rsquo;objectif \u00e9tait d&rsquo;obtenir des informations sur la fatigue, la participation dans la vie quotidienne et la qualit\u00e9 de vie des patients.<\/p>\n<p class=\"spip\">Les r\u00e9sultats publi\u00e9s en ao\u00fbt 2014 ont montr\u00e9 un niveau \u00e9lev\u00e9 de fatigue, une d\u00e9t\u00e9rioration de la qualit\u00e9 de vie et de la participation dans la vie quotidienne ainsi qu&rsquo;un taux de mortalit\u00e9 plus \u00e9lev\u00e9 que dans la population g\u00e9n\u00e9rale. L&rsquo;apparition de l&rsquo;enzymoth\u00e9rapie substitutive en 2006 a permis d&rsquo;am\u00e9liorer ces variables et de r\u00e9duire le taux de mortalit\u00e9.<\/p>\n<p class=\"spip\">La r\u00e9alisation d&rsquo;une enqu\u00eate longitudinale aupr\u00e8s des patients s&rsquo;est r\u00e9v\u00e9l\u00e9e \u00eatre un outil fiable pour d\u00e9crire, \u00e0 travers leur exp\u00e9rience, l&rsquo;histoire naturelle de la maladie de Pompe et les effets de l&rsquo;enzymoth\u00e9rapie substitutive \u00e0 long terme.<\/p>\n<p class=\"spip\"><b class=\"spip\">Ten years of the international Pompe survey\u00a0: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease.<\/b><\/p>\n<p class=\"spip\">van der Meijden JC, G\u00fcng\u00f6r D, Kruijshaar ME, Muir AD, Broekgaarden HA, van der Ploeg AT.<\/p>\n<p class=\"spip\"><b class=\"spip\">J Inherit Metab Dis. 2014 (Aout). [Epub ahead of print]<\/b><\/p>\n<p class=\"spip\">Sources\u00a0: Site AFM-T\u00e9l\u00e9thon, \u00ab\u00a0Une enqu\u00eate longitudinale sur 10 ans\u00a0\u00bb<\/p>\n<p class=\"spip\"><a href=\"http:\/\/www.afm-telethon.fr\/actualites\/maladie-pompe-enquete-longitudinale-sur-10-ans-3052\/\" target=\"_blank\">http:\/\/www.afm-telethon.fr\/actualites\/maladie-pompe-enquete-longitudinale-sur-10-ans-3052<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une \u00e9quipe a r\u00e9alis\u00e9 une enqu\u00eate longitudinale aupr\u00e8s de patients pour \u00e9valuer l&rsquo;impact de la maladie sur leur vie quotidienne. Une \u00e9tude anglo-n\u00e9erlandaise rapporte les r\u00e9sultats d&rsquo;une enqu\u00eate longitudinale r\u00e9alis\u00e9e sur 10 ans (de 2002 \u00e0 2013) aupr\u00e8s de 408 enfants et adultes atteints de maladie de Pompe dans le monde. L&rsquo;objectif \u00e9tait d&rsquo;obtenir desLeer M\u00e1s<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[19,14],"tags":[],"_links":{"self":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/495"}],"collection":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/comments?post=495"}],"version-history":[{"count":1,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/495\/revisions"}],"predecessor-version":[{"id":496,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/posts\/495\/revisions\/496"}],"wp:attachment":[{"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/media?parent=495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/categories?post=495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.glycogenoses.org\/st_qlfctn\/wp-json\/wp\/v2\/tags?post=495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}